A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages

Journal of Alternative and Complementary Medicine

Volumn 12, Issue 10, 2006, Pages 941-942

  Chen, Zhe ^a   Li, Bai ^a   Yue, Xiaoqiang ^a   Zhu, Dezeng ^a   Yu, Chaoquin ^a   Wu, Mengchao ^b   Ling, Chanquan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CINOBUFACINI; GLUTATHIONE; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHINESE MEDICINE; HUMAN; LETTER; LIVER CANCER; LIVER FUNCTION; LIVER PROTECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DRUGS, CHINESE HERBAL; HUMANS; LIVER NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846235176     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2006.12.941     Document Type: Letter

References (3)

1. Wu MC. Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existing problems. Zhong Xi Yi Tie He Xue Bao 2003;1:163-164.
2. Liver Cancer Panel of the Chinese Anti-Cancer Association. The criteria for clinical diagnosis of primary liver cancer. Zhonghua Gan Zang Bing Za Zhi 2001;9:324.
3. Ling CQ. Problems in cancer treatment and major research of integrative medicine. Zhong Xi Yi Jie He Xue Bao 2003;1:168-170.